This study also revealed a positive correlation between AZU and CD63 in patients with gingivitis, confirming that high levels of these biomarkers may reflect an increase in an innate immune response and activation of neutrophils in patients with periodontal diseases. The gene discussed is CD63; the disease is periodontal disorder.